Novel crosslinked alginate/hyaluronic acid hydrogels for nerve tissue engineering

Frontiers of Materials Science

Volumn 7, Issue 3, 2013, Pages 269-284

  Wang, Min Dan ^a   Zhai, Peng ^a   Schreyer, David J ^a   Zheng, Ruo Shi ^b   Sun, Xiao Dan ^b   Cui, Fu Zhai ^b   Chen, Xiong Biao ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

alginate; hyaluronic acid (HA); hydrogel scaffold; nerve injury; tissue engineering

Indexed keywords

EID: 84881610182     PISSN: 2095025X     EISSN: 20950268     Source Type: Journal    
DOI: 10.1007/s11706-013-0211-y     Document Type: Article

References (39)

1. Causa F, Netti P A, Ambrosio L. A multi-functional scaffold for tissue regeneration: the need to engineer a tissue analogue. Biomaterials, 2007, 28(34): 5093-5099.
2. Hollister S J. Porous scaffold design for tissue engineering. Nature Materials, 2005, 4(7): 518-524.
3. Mondrinos M J, Dembzynski R, Lu L, et al. Porogen-based solid freeform fabrication of polycaprolactone-calcium phosphate scaffolds for tissue engineering. Biomaterials, 2006, 27(25): 4399-4408.
4. Malda J, Woodfield T B, van der Vloodt F, et al. The effect of PEGT/PBT scaffold architecture on the composition of tissue engineered cartilage. Biomaterials, 2005, 26(1): 63-72.
5. Burd D A R, Ritz M, Regauer S, et al. Hyaluronan and wound healing: a new perspective. British Journal of Plastic Surgery, 1991, 44(8): 579-584.
6. Ozgenel G Y. Effects of hyaluronic acid on peripheral nerve scarring and regeneration in rats. Microsurgery, 2003, 23(6): 575-581.
7. Lee H S, Kim J C. Effect of amniotic fluid in corneal sensitivity and nerve regeneration after excimer laser ablation. Cornea, 1996, 15(5): 517-524.
8. Ikeda K, Yamauchi D, Osamura N, et al. Hyaluronic acid prevents peripheral nerve adhesion. British Journal of Plastic Surgery, 2003, 56(4): 342-347.
9. Peattie R A, Nayate A P, Firpo M A, et al. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials, 2004, 25(14): 2789-2798.
10. Khaing Z Z, Milman B D, Vanscoy J E, et al. High molecular weight hyaluronic acid limits astrocyte activation and scar formation after spinal cord injury. Journal of Neural Engineering, 2011, 8(4): 046033.
11. Struve J, Maher P C, Li Y Q, et al. Disruption of the hyaluronanbased extracellular matrix in spinal cord promotes astrocyte proliferation. Glia, 2005, 52(1): 16-24.
12. Bourguignon L Y W, Peyrollier K, Gilad E, et al. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to β-catenin nuclear translocation, transcriptional upregulation, and cell migration in ovarian tumor cells. The Journal of Biological Chemistry, 2007, 282(2): 1265-1280.
13. Aruffo A, Stamenkovic I, Melnick M, et al. CD44 is the principal cell surface receptor for hyaluronate. Cell, 1990, 61(7): 1303-1313.
14. Entwistle J, Hall C L, Turley E A. HA receptors: regulators of signalling to the cytoskeleton. Journal of Cellular Biochemistry, 1996, 61(4): 569-577.
15. Hou S, Xu Q, Tian W, et al. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. Journal of Neuroscience Methods, 2005, 148(1): 60-70.
16. Tian W M, Hou S P, Ma J, et al. Hyaluronic acid-poly-D-lysine-based three-dimensional hydrogel for traumatic brain injury. Tissue Engineering, 2005, 11(3-4): 513-525.
17. Tian WM, Zhang C L, Hou S P, et al. Hyaluronic acid hydrogel as Nogo-66 receptor antibody delivery system for the repairing of injured rat brain: in vitro. Journal of Controlled Release, 2005, 102(1): 13-22.
18. Wei Y-T, He Y, Xu C-L, et al. Hyaluronic acid hydrogel modified with nogo-66 receptor antibody and poly-L-lysine to promote axon regrowth after spinal cord injury. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2010, 95B(1): 110-117.
19. Perets A, Baruch Y, Weisbuch F, et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. Journal of Biomedical Materials Research Part A, 2003, 65A(4): 489-497.
20. Tobias C A, Dhoot N O, Wheatley M A, et al. Grafting of encapsulated BDNF-producing fibroblasts into the injured spinal cord without immune suppression in adult rats. Journal of Neurotrauma, 2001, 18(3): 287-301.
21. Suzuki K, Suzuki Y, Ohnishi K, et al. Regeneration of transected spinal cord in young adult rats using freeze-dried alginate gel. Neuroreport, 1999, 10(14): 2891-2894.
22. Suzuki Y, Kitaura M, Wu S, et al. Electrophysiological and horseradish peroxidase-tracing studies of nerve regeneration through alginate-filled gap in adult rat spinal cord. Neuroscience Letters, 2002, 318(3): 121-124.
23. Prang P, Muller R, Eljaouhari A, et al. The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials, 2006, 27(19): 3560-3569.
24. Khalil S, Nam J, Sun W. Multi-nozzle deposition for construction of 3D biopolymer tissue scaffolds. Rapid Prototyping Journal, 2005, 11(1): 9-17.
25. Haug A, Larsen B, Samuelsson B, et al. The solubility of alginate at low pH. Acta Chemica Scandinavica, 1963, 17(6): 1653-1662.
26. Nakajima N, Ikada Y. Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media. Bioconjugate Chemistry, 1995, 6(1): 123-130.
27. Danishefsky I, Siskovic E. Conversion of carboxyl groups of mucopolysaccharides into amides of amino acid esters. Carbohydrate Research, 1971, 16(1): 199-205.
28. LeRoux M A, Guilak F, Setton L A. Compressive and shear properties of alginate gel: effects of sodium ions and alginate concentration. Journal of Biomedical Materials Research, 1999, 47(1): 46-53.
29. Rowley J A, Madlambayan G, Mooney D J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials, 1999, 20(1): 45-53.
30. Pouyani T, Prestwich G D. Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials. Bioconjugate Chemistry, 1994, 5(4): 339-347.
31. Suri S, Schmidt C E. Cell-laden hydrogel constructs of hyaluronic acid, collagen, and laminin for neural tissue engineering. Tissue Engineering Part A, 2010, 16(5): 1703-1716.
32. Campbell W W. Evaluation and management of peripheral nerve injury. Clinical Neurophysiology, 2008, 119(9): 1951-1965.
33. Papastefanaki F, Chen J, Lavdas A A, et al. Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury. Brain, 2007, 130(8): 2159-2174.
34. Hill C E, Moon L D, Wood P M, et al. Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia, 2006, 53(3): 338-343.
35. Oudega M, Xu X M. Schwann cell transplantation for repair of the adult spinal cord. Journal of Neurotrauma, 2006, 23(3-4): 453-467.
36. Goto E, Mukozawa M, Mori H, et al. A rolled sheet of collagen gel with cultured Schwann cells: model of nerve conduit to enhance neurite growth. Journal of Bioscience and Bioengineering, 2010, 109(5): 512-518.
37. Deng L X, Hu J, Liu N, et al. GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury. Experimental Neurology, 2011, 229(2): 238-250.
38. Sherman L, Skroch-Angel P, Moll J, et al. Schwann cell tumors express characteristic patterns of CD44 splice variants. Journal of Neuro-Oncology, 1995, 26(3): 171-184.
39. Maharjan A S, Pilling D, Gomer R H. High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation. PLoS ONE, 2011, 6(10): e26078-e26087.